Rhode Island Chronicle

Genomics Market – DataM Intelligence

Market Overview:

The branch of biology known as genomics focuses on understanding an organism’s entire gene or genetic makeup (DNA). It entails deciphering and evaluating the structure, operation, evolution, and interaction of genes as well as how these factors affect the traits and behaviours of an organism. Due to advances in DNA sequencing and analysis technology over the past few decades, genomics market has developed quickly.

Market Size Growth Rate:

According to the DataM market research report, the global genomics market size is valued at USD 27.9 billion in 2022, it is expected to reach USD 115.4 billion by 2030, with growth at a CAGR of 18.7% over the forecast period 2023-2030. North America is estimated to contribute 38.2% to the growth of the global market over the forecast period.

The global genomics market is driven by factors such as technological advancements, personalized medicine, pharmaceutical development, and regulatory support. On the other hand, the high cost of research and development, and regulatory challenges restrain market growth.

For More Insights about the Market Request Free Sample Here: https://www.datamintelligence.com/download-sample/genomics-market

Market Drivers:

The increasing research activities drive the genomics market. For instance, in August 2023, in order to better understand how pediatric patients with genetic diseases might receive timely diagnoses, PacBio and GeneDx launched a research partnership with the University of Washington. 350 individuals, including 120 participants in the SeqFirst WGS trial at Seattle Children’s Hospital, as well as their biological parent’s duos and trios where available will have their samples subjected to WGS sequencing and analysis by GeneDx. 

In order to determine whether novel variations that were previously inaccessible by short-read sequencing methods may be the cause of some genetic disorders, both short-read and long-read WGS will be used. 

Market Restraints:

Even though genome sequencing has grown more widely available, effectively analyzing the enormous amount of genetic data is still a challenging undertaking. It can be difficult to examine and comprehend the functional implications of genetic variants. Genomic data is vast and intricate. Billion data points are produced during the sequencing of a single genome, and specialized equipment and processing power are needed to analyze this data. 

It can be difficult to recognize and comprehend genetic variations, including single nucleotide polymorphisms (SNPs) and structural variants. Complex algorithms and databases of known variations are needed to distinguish between benign and disease-causing variants.

Market Opportunities:

Technological advancements open up new market opportunities. For instance, in October 2022, Illumina Inc., a leader in DNA sequencing and array-based technologies, and AstraZeneca, a leading biopharmaceutical company with a global focus on science, joined forces to accelerate the discovery of drug targets by combining their strengths in artificial intelligence (AI) based genome interpretation and genomic analysis techniques with industry knowledge. In order to find prospective therapeutics based on human omics insights, the cooperation will assess whether a combined framework of these technologies may boost the yield and confidence of target identification. 

View Full Report: https://www.datamintelligence.com/research-report/genomics-market

COVID-19 Impact Analysis:

For identifying and keeping track of COVID-19 infections, genomic tools like PCR and next-generation sequencing (NGS) have proved essential. While NGS can offer a more comprehensive view of viral variations, PCR techniques focus on a particular piece of viral genetic material. Monitoring the transmission of COVID-19 and tracing its mutations has been greatly aided by genomics. The identification of novel viral variants, including those that may have effects on transmission and vaccine effectiveness, has been made possible by the sequencing of viral genomes from various samples.

Russia-Ukraine War Impact Analysis:

Due to Russia Ukraine conflict collaborations slowed down it affected research institutes, universities, or laboratories engaged in genomics research. Accessing resources like facilities, data, or samples may prove difficult for researchers, which could continue their work. In addition, investor confidence and the availability of capital can be affected by geopolitical turmoil. The pace of innovation and research may be impacted if the conflict’s unpredictability impacts the funding sources for genomics startups, research projects, or businesses in the affected areas.

Recent Developments in the Industry:

1. In June 2023, the University of Texas MD Anderson Cancer Center and Myriad Genetics, Inc., a pioneer in genetic testing and precision medicine, have partnered to promote research on the choice and effectiveness of treatment for metastatic renal cell carcinoma. The study will make use of Myriad’s minimal residual disease (MRD) testing platform, a high-definition assay that recognizes circulating tumor DNA (ctDNA) and is informed by tumors.
2. In March 2023, in cooperation with its local partner, Zentya, BGI Genomics released the COLOTECTTM 1.0 in Slovakia. Zentya is a Slovak-based provider of healthcare solutions that is passionate about giving patients access to the most advanced genetic screening technology in order to help diagnose and expedite the treatment of genetic illnesses.

Market Segmentation:

As per the research analysis, the global genomics market is segmented by application & technology (functional genomics (transfection, real-time PCR, RNA interference, mutational analysis, SNP analysis, microarray analysis), epigenomics (bisulfite sequencing, chromatin immunoprecipitation (ChIP & ChIP-Seq), methylated DNA immunoprecipitation (MeDIP), high-resolution melt (HRM), chromatin accessibility assays, microarray analysis), pathway analysis (bead-based analysis, microarray analysis, real-time PCR, proteomics tools), biomarker discovery (mass spectrometry, real-time PCR, microarray analysis, statistical analysis, bioinformatics, DNA sequencing), others) deliverables (products (instruments/systems/software and consumables & reagents), services (NGS-based services, core genomics services, biomarker translation services, computational services, others) end-user (clinical research, academic & government institutes, hospitals & clinics, pharmaceutical & biotechnology companies, others).

1. Based on application and technology, the functional genomics segment is estimated to contribute 34.3% to the growth of the global market over the forecast period (2023-2030). A critical mass of neurogenetic findings has been made as a result of advancements in functional genomic annotation. Hereditary ataxia, a diverse collection of illnesses characterized by incoordination due to cerebellar damage, serves as an example of this. A thorough genetic categorization divided by age of onset has been created as a result of associated pathogenic variations in more than 300 genes being described. 
2. In addition, quantitative PCR, commonly known as real-time polymerase chain reaction (real-time PCR), is a variation of the PCR method that enables real-time monitoring of the PCR progress. In vitro, the amplification of a chosen DNA area across several orders of magnitude using the PCR method results in hundreds to millions of copies of a particular DNA segment.

Geographical Classification:

The global genomics market is segmented into major countries, including North America, Europe, South America, Asia Pacific, and Middle East & Africa.

North America Genomics Market:

The demand for genomic testing and analysis services has increased as people become more aware of the potential advantages of personalized medicine. Consumer interest in knowing their genetic susceptibility to diseases and making educated healthcare decisions is growing. Innovative genomics technologies, such as high-throughput techniques and next-generation sequencing (NGS) platforms, have been developed and used most rapidly in North America. The analysis and sequencing of the human genome have become faster and more affordable because of these technologies.

Asia-Pacific Genomics Market:

There is a demand for genomics-based methodologies in drug discovery, development, and clinical trials as a result of the expansion of the biotechnology and pharmaceutical industries in the area. A number of nations in the Asia-Pacific area have started genomics projects to promote study, invention, and technological advancement. These initiatives frequently involve finance, the creation of infrastructure, and policy backing.

Europe Genomics Market:

People can better comprehend the advantages and implications of genetic information due to ongoing efforts to raise public awareness and educate the public about genomics. Europe places a high priority on the study of rare diseases, and genomics is essential for determining the genetic underpinnings of these conditions and creating focused treatments.

Competitive Analysis:

There are numerous international, regional, and local suppliers in the global genomics industry. The competition in the local market is fierce. The vendors compete based on price, product quality, and dependability. As a result, to prosper and survive in a competitive market, suppliers must provide cost-efficient and effective products.

Major Companies:

Major companies working towards the market’s growth include Agilent Technologies, Bio-Rad Laboratories, Inc., BGI Genomics, Color Genomics, Inc., Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche Ltd., GE Healthcare, Illumina, Inc., and Myriad Genetics, Inc., and others.   

Related Reports

• Genome Editing Market
• Genomic Biomarker Market

Additional Benefits Post Purchase:

1) Unlimited Analyst support for a period of 1 year. 

2) Any query with regard to the scope offered will be addressed within 24- 48 hours.

3) An Excel sheet with market numbers will be provided separately.

The Full Report has the below insights: 

• The report offers a comprehensive evaluation of the market in terms of market value (US) and Y-o-Y Growth Rates (%). It does so via in-depth qualitative insights, historical data (2021-2022), and verifiable projections about market size during the forecast period (2023-2030).
• Visualize the composition of the global Genomics market segmentation by mode, product, services, and region, highlighting the key commercial assets and players. 
• By Product: Application & Technology (Functional Genomics (Transfection, Real-Time PCR, RNA Interference, Mutational Analysis, SNP Analysis, Microarray Analysis), Epigenomics (Bisulfite Sequencing, Chromatin Immunoprecipitation (ChIP & ChIP-Seq), Methylated DNA Immunoprecipitation (MeDIP), High-Resolution Melt (HRM), Chromatin Accessibility Assays, Microarray Analysis), Pathway Analysis (Bead-Based Analysis, Microarray Analysis, Real-time PCR, Proteomics Tools), Biomarker Discovery (Mass Spectrometry, Real-time PCR, Microarray Analysis, Statistical Analysis, Bioinformatics, DNA Sequencing), Others). 
• By Deliverables: Products (Instruments/Systems/Software and Consumables & Reagents), Services (NGS-based Services, Core Genomics Services, Biomarker Translation Services, Computational Services, Others).   
• By End User: Clinical Research, Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others. 
• By Region: North America, South America, Europe, Asia Pacific, Middle East & Africa.
• Identify commercial opportunities in the global Genomics market by analyzing trends and co-development deals.
• The report also covers data insights on various industry forces such as Porter’s five forces analysis, supply chain analysis, pricing analysis, and regulatory analysis.
• Excel data sheet with thousands of data points of global Genomics market-level 4/5 segmentation.
• PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study. 
• Product mapping in Excel for the key product of all major market players
• The report will provide access to approximately 61 market data tables, 64 figures, and close to 180 pages. 

About Us:

DataM Intelligence 4Market Research is a market intelligence platform that gives access to syndicated, customized reports and consulting to its clients in one place. As a firm with rich experience in research and consulting across multiple domains, we are a one-stop solution that will cater to the needs of clients in key business areas. DataM Intelligence has an online platform whose coverage includes industries such as chemicals and materials, agriculture, health care services, animal feed, and food & beverages among others. Our platform has Insights on markets that uncover the latest market research data that are distinct from the competition. With coverage across 10 major industries in the marketplace research, DataM Intelligence benefits thousands of companies by helping them take their innovations early to the market by providing a complete view of the market with statistical forecasts. Our strategy centric framework and value-added services will let individuals and corporates with ease of access and custom personalization to research and markets.

Media Contact
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Send Email
Phone: 08774414866
Address:DATAM INTELLIGENCE 4MARKET RESEARCH LLP Ground floor, DSL Abacus IT Park, Industrial Development Area, Uppal, Hyderabad, Telangana 500039
City: HYDERABAD
State: Telangana
Country: India
Website: https://www.datamintelligence.com/research-report/genomics-market